| Literature DB >> 36080298 |
Emma H Acosta-Jiménez1, Luis A Zárate-Hernández1, Rosa L Camacho-Mendoza1, Simplicio González-Montiel1, José G Alvarado-Rodríguez1, Carlos Z Gómez-Castro1, Miriam Pescador-Rojas2, Amilcar Meneses-Viveros3, Julián Cruz-Borbolla1.
Abstract
Compounds containing carbamate moieties and their derivatives can generate serious public health threats and environmental problems due their high potential toxicity. In this study, a quantitative structure-toxicity relationship (QSTR) model has been developed by using one hundred seventy-eight carbamate derivatives whose toxicities in rats (oral administration) have been evaluated. The QSRT model was rigorously validated by using either tested or untested compounds falling within the applicability domain of the model. A structure-based evaluation by docking from a series of carbamates with acetylcholinesterase (AChE) was carried out. The toxicity of carbamates was predicted using physicochemical, structural, and quantum molecular descriptors employing a DFT approach. A statistical treatment was developed; the QSRT model showed a determination coefficient (R2) and a leave-one-out coefficient (Q2LOO) of 0.6584 and 0.6289, respectively.Entities:
Keywords: DFT; QSTR; acetylcholinesterase; carbamates; toxicity
Mesh:
Substances:
Year: 2022 PMID: 36080298 PMCID: PMC9457808 DOI: 10.3390/molecules27175530
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Twelve molecules randomly selected to represent the entire set of carbamates; the numbers are the ids from ChemID (Full set is reported in supplementary material).
Figure 23D structure and frontier molecular orbitals of the twelve molecules selected randomly (full set is reported in supplementary materials, Figure S2).
Model data for twelve compounds randomly selected; EA is in eV and qC in C, the other quantities are dimensionless.
|
|
| log(1/C) |
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0000126523 | Test | −0.29657 | −8.643 | 0.1862 | 1.528 | 0.438 | 0.091 | 1 | 1 | 1 | 0 | 1 |
| 0000886748 | Training | −0.48124 | −7.7613 | 0.1931 | 2.25 | 0.424 | 0.26 | 0 | 1 | 1 | 1 | 1 |
| 0001967164 | Training | −1.02699 | −7.9976 | 0.198 | 2.071 | 0.415 | 0.257 | 0 | 0 | 1 | 0 | 0.5 |
| 0002655143 | Training | −0.13579 | −7.9584 | 0.1875 | 1.662 | 0.43 | 0.06 | 0 | 0 | 1 | 0 | 1 |
| 0003942710 | Training | −0.38243 | −7.8397 | 0.1869 | 1.697 | 0.432 | 0.093 | 1 | 0 | 1 | 0 | 1 |
| 0006988201 | Training | 0.33382 | −7.938 | 0.189 | 1.403 | 0.425 | 0.112 | 0 | 0 | 1 | 0 | 1 |
| 0013887597 | Test | −0.72691 | −7.4242 | 0.1839 | 1.977 | 0.433 | 0.335 | 0 | 1 | 1 | 1 | 1 |
| 0016655826 | Training | 1.11994 | −7.6752 | 0.186 | 1.481 | 0.431 | 0.107 | 1 | 0 | 1 | 1 | 1 |
| 0018659455 | Training | 0.57246 | −7.084 | 0.1917 | 1.656 | 0.431 | 0.169 | 1 | 0 | 1 | 1 | 1 |
| 0028559004 | Training | −0.88027 | −7.7277 | 0.1988 | 2.473 | 0.429 | 0.371 | 0 | 0 | 1 | 0 | 0.5 |
| 0053380237 | Training | −0.2937 | −7.8825 | 0.1937 | 1.849 | 0.417 | 0.138 | 0 | 0 | 1 | 0 | 0.5 |
Figure 3Variables are illustrated using some compounds of the set and marked with blue on the structure.
Best obtained model, where G, L, and S means global, local, and structural descriptors respectively, Coeff mean coefficient, Std. Coeff is the standardized coefficient and Co. Int. is the confidence interval at 95%.
| Variable | Type | Coeff. | Std. Coeff. | Co. Int. |
|---|---|---|---|---|
|
| G | 0.3231 | 0.2267 | 0.2055 |
|
| L | −34.0837 | −0.1732 | 23.1746 |
|
| S | −0.6319 | −0.2946 | 0.2317 |
|
| S | −22.6053 | −0.2935 | 8.3602 |
|
| S | −1.5012 | −0.3124 | 0.6143 |
|
| S | 0.2275 | 0.1312 | 0.1733 |
|
| S | −0.6919 | −0.3527 | 0.2705 |
|
| S | 0.6524 | 0.1764 | 0.374 |
|
| S | 0.3996 | 0.2365 | 0.1956 |
|
| S | 0.6244 | 0.2671 | 0.2492 |
|
| - | 18.7033 | - | 6.3069 |
Correlation matrix between variables of the model.
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|
|
| 1.00 | |||||||||
|
| 0.12 | 1.00 | ||||||||
|
| −0.31 | 0.17 | 1.00 | |||||||
|
| −0.09 | −0.32 | 0.05 | 1.00 | ||||||
|
| 0.44 | 0.09 | −0.22 | −0.16 | 1.00 | |||||
|
| −0.08 | −0.09 | −0.05 | 0.19 | 0.02 | 1.00 | ||||
|
| −0.37 | −0.45 | 0.14 | 0.25 | 0.19 | 0.08 | 1.00 | |||
|
| 0.32 | −0.07 | −0.05 | 0.00 | 0.14 | 0.12 | −0.12 | 1.00 | ||
|
| 0.43 | −0.13 | −0.16 | 0.01 | 0.43 | −0.07 | 0.16 | 0.03 | 1.00 | |
|
| 0.07 | −0.25 | 0.05 | 0.33 | −0.04 | 0.24 | 0.14 | 0.14 | 0.03 | 1.00 |
Figure 4Graph of predicted values of log(1/C) vs. experimental values of log(1/C) for training set (light blue dots) and for test set (violet dots); solid line is a diagonal plot.
Figure 5Graph of predicted LOO values of log(1/C) vs. experimental values of log(1/C) for training set (light blue dots) and for test set (violet dots), solid line is a diagonal plot.
Figure 6William’s plot with an up and low limit of 3σ and −3σ respectively, for the training set (light blue dots) and for the test set (violet dots).
Figure 7Model complex of Mitomycin approaching the catalytic triad in AChE (Ser200, His440, Glu327, in green).